MediciNova Shares Are Trading Higher After the Company Announced That It Received a Notice of Allowance From the U.S. Patent and Trademark Office for a Pending Patent Application, Which Covers MN-166 for Post-COVID Conditions.
MediciNova Shares Are Trading Higher After the Company Announced That It Received a Notice of Allowance From the U.S. Patent and Trademark Office for a Pending Patent Application, Which Covers MN-166 for Post-COVID Conditions.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.